Comprehensive, Accurate, Quantitative
Metabolomics
for Biomedicine, Agriculture,
and Environment
Our Latest News and Innovations
6th Annual Canadian Metabolomics Conference
TMIC 2024: A Year of Discovery, Impact, and Innovation
Solnul: A TMIC Client Success Story
MetaboNews October Issue – Mark Viant
Metabolomics Day 2024
MetaboNews September Issue – Shuang Zhao
Work With Our Team
Multiple Platforms & Equipment
Access to over $40 million in state-of-the-art metabolomics infrastructure and technologies including using NMR, CE-MS, GCxGC MS, GC-MS, LC-MS, UPLC, HPLC and Metabolite Imaging.
One-Stop-Shop
High throughput, low cost and extremely comprehensive services from sample preparation to the data analysis and data interpretation. TMIC guarantees high quality reproducible data as well as high customer-service standards.
Various Applications
TMIC technologies are compatible with a wide range of samples, including human and animal biofluids, cell extracts and cell culture media, tissue, water, air, and soil, including small sample sizes. We serve clients in biomedical, environmental and agricultural research.
What is Metabolomics?
Metabolomics is a field of “omics” specializing in the near global analysis of small molecule metabolites (<1500 Daltons) found in biological samples.
Its applications include disease diagnostics, agriculture and livestock, food and nutrition, environmental and pharmaceutical research and development.
About TMIC
The Metabolomics Innovation Centre (TMIC) is a nationally-funded core facility supported by the Canada Foundation for Innovation (CFI) Major Science Initiatives (MSI) program, Genome Canada (GC), and other funding agencies. It possesses a unique combination of infrastructure and personnel to conduct a wide range of cutting-edge metabolomic studies for biomarker discovery, biological studies, exposomics, clinical trials research, biomedical studies, bioproducts studies, agriproduct research, nutrient profiling, and environmental testing. It operates on a cost-recovery model, utilizing the funds received, user fees collected, and university support.
The platform comprises Dr. Liang Li (University of Alberta), Dr. David Wishart (University of Alberta), Dr. Christoph Borchers (McGill University), Dr. David Goodlett (University of Victoria), Dr. James Harynuk (University of Alberta), Dr. Philip Britz-McKibbin (McMaster University), Dr. Jeff Xia (McGill University), Dr. Dajana Vuckovic (Concordia University), and Dr. Tao Huan (University of British Columbia).
